[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [aBlueprint](https://github.com/mm80843/T3.5/tree/pages/docs/aBlueprint/index.md) >> Individual ID:PBN__aBlueprint_37 

# __Implementing Innovative Techniques to Thwart Contagious Disease Spread__

## 0. Blueprints points to this category of risks

* [The prevalence and impact of inaccurate, uncertain, and biased data pose significant challenges in decision-making and effective response to the covid-19 pandemic.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_84.md)

## 1. Summary of the blueprint

* The given blueprint presents a structured approach to address the challenges associated with data accuracy, uncertainty, inconsistent findings, and misleading information, which emerge when studying contagion patterns of diseases in green building neighbourhoods. The risk spectrum largely affects researchers, policy-makers, laboratory personnel, and the general population, who are either directly engaged with the data or influenced by its implications. Implementation of these risk mitigation measures could significantly improve our understanding and reaction to the spread of diseases, particularly in settings prioritizing sustainability and eco-friendly design.

* The crux of the risks outlined in this blueprint revolves around the reliability and perception of collected data. Inaccurate data, influenced by limited sample sizes, biased results, or misinformation, poses a significant threat, leading to skewed decision-making, incorrect measurements, incorrect data analysis, and a lack of understanding of contagious diseases' spread. Specifically, in the context of green building neighbourhoods, these inaccuracies can potentially lead to incorrect conclusions about the infection risk and, in worst-case scenarios, significant public health issues.

* To mitigate these risks, the blueprint recommends several critical measures. Firstly, it encourages the consideration of possible impacts of the pandemic on data findings, with suggestions to adjust research designs and increase contextual reporting. Furthermore, aligning and reconciling data from different sources, validating data consistency and constructing expert consensus will improve information reliability. The blueprint also advocates for the optimization and validation of biomarker measurement methods, improved PCR methods, and standardization across different labs. This multi-layered approach ensures a comprehensive improvement in the handling and interpretation of data related to disease contagion.

* The benefits promised through this blueprint are multi-dimensional. Implementation will not only improve worker safety but also offer greater protection against virus transmission. Furthermore, it will bring significant enhancements in terms of individual protection measures, with implications for masks, gloves, goggles, and other personal protective equipment. Above all, the most significant gain will be a more robust, reliable understanding of contagious diseases spread in green building neighbourhoods. This knowledge will empower stakeholders to make informed, evidence-based decisions ensuring public safety while still promoting sustainable living.

## 2. Details of the blueprint

* I strongly recommend implementing the 'Blueprint' data based on the risks associated with data accuracy and misinformation presented in this context. Implementation would involve reassessing and adjusting the research design, enhancing the data collection process, and reporting additional contextual detail. It also includes measures such as aligning disparate data from various sources, validating data consistency, and building consensus among experts. Additionally, it proposes optimization and validation of biomarker measurement methods for wastewater analysis along with improved PCR methods for correct data analysis. Lastly, it calls for standardization and verification of PCR methods and protocols utilized by different laboratories to uphold uniformity and negate possible discrepancies.

* The 'Blueprint' can be implemented by stakeholders inclusive of researchers, health authorities, laboratory personnel, scientists, and research institutions.

* 'Neighbourhood'. 

* The 'Blueprint' thoroughly outlines risks tied to data accuracy, data inconsistency, ambiguity, and misleading information that can critically affect the understanding and interpretation of contagious diseases spread in infrastructure. It poses challenges for individuals directly working with the aimed data or those affected by its implications. Inaccurate data, biased results, or misinformation could potentially skew decision-making, cause inaccurate measurements, hinder accurate data analysis, and impede the proper understanding of the spread of contagious diseases.

## 3. Blueprint impacts these stakeholders

* [General population](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_9.md)
* [Laboratory personnel](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2.md)
* [Policymakers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_126.md)
* [Researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_688.md)
* [Researchers in wastewater analysis](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_689.md)

## 4. Blueprint links to these mitigations

* [Alignment and reconciliation of data from different sources, validation of data consistency, consensus-building among experts](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_1877.md)
* [Consider possible impacts of the pandemic on findings, adjust research design and data collection, report extra contextual detail.](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_3001.md)
* [Improvement of pcr methods in terms of sensitivity and comparability, optimization of rna extraction protocol.](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_1605.md)
* [Optimization and validation of biomarker measurement methods for wastewater analysis, including elisa and mass spectrometry.](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_1598.md)
* [Standardization and verification of pcr methods and protocols used by different laboratories.](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_1597.md)

## 5. Blueprint mitigation can be owned by these stakeholders

* [Health authorities](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_46.md)
* [Laboratory personnel](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_394.md)
* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_413.md)
* [Researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2.md)
* [Scientists](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_688.md)

## 6. Blueprint links to these benefits

* [Improved worker safety](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_411.md)
* [Protection against virus transmission](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_502.md)
* [Protection of individuals](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_1337.md)

## 7. Blueprint links to these technology

* [Etc.](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_22.md)
* [Face masks](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_340.md)
* [Face shields](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_2341.md)
* [Gloves](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_1051.md)
* [Goggles](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_2635.md)
* [Masks](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_2727.md)
* [Ppe](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_484.md)
* [Protective clothing](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_1461.md)
* [Reverse transcriptase quantitative polymerase chain reaction rt-qpcr](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_485.md)

